iNANOD AS is a nanotechnology based anticancer drug developing company operating from Oslo Cancer Cluster Incubator established in 2016.

The objective is to increase efficacy of cancer drugs and to reduce unintended side-effects for cancer patients and maximize their longevity. We have a strong group of people to deliver on the promise which comprises of our collaborators, scientific advisors and business advisors. Our aim is to become a pharmaceutical company for anti cancer nanomedicines. We will take a comprehensive approach, using collaborative research from many small projects and existing literature and infrastructure.